Abajar, Irenito T.
HRN: 15-38-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/03/2024
02/09/2024
IV
2.25g
Q8
Complicated Pleural Effusion, Right Sec To Parapneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes